MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the filing statement related to the imminent listing, by way of a reverse takeover, of MediPharm Labs, Inc. on the TSX Venture Exchange.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached news release confirming that Up Cannabis Inc., a wholly-owned subsidiary of Newstrike Brands Ltd (CVE:HIP), has entered into an agreement with MediPharm Labs Inc. to supply up to 1,200 kilograms of cannabis flower and shake that will be used for the purpose of extraction and the creation of cannabis oil and/or distillate.
Collaborate Corporation Limited (ASX:CL8) is pleased to confirm the despatch today of the prospectus as lodged with ASIC and ASX on 14 September 2018, including the entitlement and acceptance form, for the partially underwritten non-renounceable entitlement issue of shares to raise approximately $1.16 million before costs.
MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's Annual Report to shareholders.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached announcement confirming that Fire & Flower Inc. proposes to list on the TSX Venture Exchange by way of a reverse takeover transaction.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the interview with Proactive Investors Vancouver given by Pat McCutcheon, President and CEO of MediPharm Labs, Inc., providing a detailed description of their business and revenue model.
The Board of MNF Group Limited (ASX:MNF) is pleased to advise that the subscription price for the Dividend Reinvestment Plan applicable to the 2018 final dividend is $4.63 per share.
